Imprimis Pharmaceuticals Inc. (IMMY) Trading Up 2.9%
Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY)’s share price was up 2.9% on Wednesday . The stock traded as high as $4.41 and last traded at $4.22, with a volume of 65,629 shares changing hands. The stock had previously closed at $4.10.
Separately, Zacks Investment Research raised Imprimis Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Monday, July 18th.
The stock has a 50 day moving average of $3.88 and a 200-day moving average of $3.93. The company’s market cap is $54.43 million.
Imprimis Pharmaceuticals (NASDAQ:IMMY) last released its earnings results on Monday, August 15th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter. The firm had revenue of $4.90 million for the quarter, compared to analysts’ expectations of $4.53 million. Analysts forecast that Imprimis Pharmaceuticals Inc. will post ($0.94) EPS for the current year.
Imprimis Pharmaceuticals, Inc (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.